General Information
Revision date
2020-03-17
Product name
Amprenavir
CAS No.
161814-49-9
1.2.1 Relevant identified uses
Reference material for laboratory use only
Emergency telephone
department
Icons in SDS
Company Information
company name
LGC Standards
e-mail address of the competent person responsible for the Safety Data Sheet
lgcusa@lgcgroup.com, sds-request@lgcgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H361, H362
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
2.1 Classification of the substance or mixture
GHS08 Health hazard Carc. 2 H351 Suspected of causing cancer. Repr. 2 H361-H362 Suspected of damaging fertility or the unborn child. May cause harm to breast-fed children.
2.2 Label elements
The substance is classified and labeled according to the Globally Harmonized System (GHS).
Hazard pictograms
GHS08
Signal word
Contd. on page 2) US (Contd. of page 1)
Hazard statements
H351 Suspected of causing cancer. H361-H362 Suspected of damaging fertility or the unborn child. May cause harm to breast-fed children.
Precautionary statements
P260 Do not breathe dusts or mists. P263 Avoid contact during pregnancy/while nursing. P280 Wear protective gloves/protective clothing/eye protection/face protection. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Classification system
NFPA ratings (scale 0 - 4) Health = 0 0 Fire = 0 0 0 Reactivity = 0 · HMIS-ratings (scale 0 - 4) HEALTH 0 Health = 0 FIRE 0 Fire = 0 REACTIVITY 0 Reactivity = 0
PBT Substances
Not applicable
vPvB Substances
Not applicable
